On January 10, 2025, Health Gene Tech's partner appreciation event, themed “Integrity and Innovation, Driven by Commitment”, was held at the Shangri-La Hotel in Ningbo. Core partners from across the country gathered to share experiences, discuss development, and forge mutually-beneficial collaboration!
At the beginning of the meeting, Ding Yu, Chairman and CEO of Health Gene Technologies, delivered a welcome speech, extending a warm welcome and sincere gratitude to the guests and partners in attendance. In this era of change and opportunity, Health Gene Tech is fortunate to be able to work together with everyone to face the ever-changing market conditions.
Ding Yu, Chairman and CEO of HGT
This grand event focused on discussing the new landscape and emerging trends facing the IVD market in the current environment, with the aim of working together with all sectors to formulate long-term strategies, promote high-quality progress, and overcome new challenges. HGT empowers distributors, through innovative products, ushers in a new era of prosperity and development for the IVD industry!
Adapting to Trends, Defying Adversity
Wentao Hu, General Manager of Clinical Diagnostic Division of Health Gene Technologies, reviewed the multiple challenges facing the IVD industry in 2024. Against this backdrop, Health Gene Tech performed exceptionally well, effectively responding to industry shocks and demonstrating its strong capabilities through highlights such as academic marketing activities, multi-channel business development, the launch of its JD.com store, selection in the centralized procurement of IVD reagents, breakthroughs in military hospitals, and strategic cooperation with Beckman Coulter.
Wentao Hu, General Manager of Clinical Diagnostic Division of HGT
The company adheres to the principle of adhering to core values while innovating, guided by its mission and values. It leverages its CE advantages, expands its technical capabilities, and innovates in multiple dimensions to diversify its product portfolio and explore new markets and business models. By forging ahead with determination, the company has established a comprehensive presence in the IVD field, flexibly adapting to policy changes while providing professional academic support and premium services, thereby maintaining a steady growth trajectory.
Sailing Ahead with Momentum
Jianmin Liu, General Manager of Health Manufacturing, introduced chemical luminescence product solutions. The magnetic particle chemical luminescence reagent kit, equipped with a newly developed fully automatic chemical luminescence immunoassay analyzer, drives innovation in chemiluminescence diagnostics platforms and provides users with more comprehensive in vitro diagnostic product solutions.
Jianmin Liu, General Manager of Health Manufacturing
Health Manufacturing has entered into a strategic alliance with Beckman Coulter, providing the company with robust technical empowerment and opportunities for collaborative innovation. Through joint efforts, the two parties aim to bring more innovative products and services to China's healthcare market, enhancing the efficiency and accuracy of laboratory and clinical diagnostics, and benefiting more patients.
Innovation and Development
Zhongnan Bai, General Manager of the Applied Science Division of Health Gene Technologies, shared the achievements and highlights of new products in 2024. In this era of intense competition, we have delivered satisfactory results in both the domestic and overseas markets. Additionally, we outlined plans and outlook for the 2025 RUO (Research Use Only) product line, aiming to expand product applications, cover industries through applications, and break away from traditional thinking to develop multi-dimensional, innovative industry solutions based on existing core product technologies.
Zhongnan Bai, General Manager of the Applied Science Division of HGT
“Honor The Legacy, Pioneer The Future” is our commitment to collaborate with partners. Moving forward, we will pursue new-quality innovation, break through barriers, create diversified application solutions, and drive development.
Future-Insight Within
Ding Yu, Chairman and CEO of Health Gene Technologies, said that the company has taken firm and effective steps in actively exploring new fields and cutting-edge technologies. We closely observe industry trends and, with a forward-looking vision, lay out emerging technology directions in advance, striving to seize opportunities at the source of technology and lay a solid foundation for the company's long-term development.
Ding Yu, Chairman and CEO of HGT
While fully exploring new fields, the company remains true to its original mission and continues to deepen its expertise in the CE field. The successful research, development, and application of the CE Ultra-Multi PALACE new technology have injected powerful momentum into the single-tube multiplex product line. The ability to achieve precise detection of ultra-multiple target markers within the same reaction tube effectively reduces costs and provides more convenient and efficient solutions for clinical diagnosis.
Looking to the future, the company will continue to uphold an innovation-driven development philosophy, increase R&D investment, and break through technical barriers. It will launch innovative molecular diagnostic products, strengthen cooperation with upstream and downstream enterprises, and jointly promote the healthy and rapid development of the testing industry.
Outstanding Partner Recognition
Over the past year, Health Gene Tech has achieved significant growth in sales and market share, while also elevating its brand influence and reputation to new heights. These achievements would not have been possible without the unwavering support and relentless efforts of all our distributor partners.
At the event, outstanding distributor partners were specially recognized. These awards not only serve as a high commendation for their exceptional contributions but also symbolize our deep trust, profound respect, and sincere gratitude.
Health Gene Tech will continue to work hand in hand with our outstanding distributor allies, consistently adhering to our business philosophy of being market-driven, customer-oriented, quality-focused, innovation-driven, service-supported, and collaboration-based. We will unite our efforts, walk side by side, and strive tirelessly on the path to excellence, jointly charting a brighter and more glorious future for Health Gene Tech!
